Disease Landscape

Gone are the days when physicians were the sole decision-makers in a patient’s treatment.  Today, physician, payer, patient and policymaker all converge to influence treatment availability and choice.

Deep insight into these complex and evolving relationships is essential to anticipate opportunities and challenges and to create products supported by data that is relevant and compelling to each stakeholder.

Clarion creates rich, foundational understanding of disease states:

Landscape Assessments and Opportunity Identifications

• Rapid profiling of tumor landscape
• Pipeline and future competitor profiling
• Development of initial value proposition and hypotheses for novel product introductions
• High level market sizing

ATLAS:360 (Assessment of Tumor Landscape and Stakeholders: 360°View)

• Deep and rigorous, quantitative evaluation of the patient flow and care algorithm (aka Buying Process)—in both current and future markets
• 360° view of the disease market and the needs of stakeholders—including patients, payers and key HCPs
• Identification of leverage points in the marketplace, i.e. those investments critical to the success of the product